Jiamusi Xingyu Biotechnology Development Co., Ltd
Jiamusi Xingyu Biotechnology Development Co., Ltd. (hereinafter referred to as Xingyu Biotechnology) was established in December 2001 and is now a wholly-owned subsidiary of Deqiang Biotechnology Co., Ltd. National designated pesticide enterprise, ma
Introduction
Jiamusi Xingyu Biotechnology Development Co., Ltd. (hereinafter referred to as Xingyu Biotechnology) was established in December 2001 and is now a wholly-owned subsidiary of Deqiang Biotechnology Co., Ltd. National designated pesticide enterprise, mainly researching and developing antibiotic synthetic pollution-free pesticide raw material series products and formulation series products, mainly engaged in methomyl salt raw materials and formulations.
Information
Categories
More Websites
The company's main products include thiamethoxam, metoclopramide, fluoxetine, clotrimazole, tebuconazole, and enoxystrobin; Imidazole, Triazole, Sodium Triazole, 2-aminothiazole, 2-amino-5-methylthiazole, 2-amino-5-nitrothiazole, 4,6-dichloropyrimidi
EOC started mid 20th century as a producer of foam rubber for the mattress and furniture sectors. Along the way it shifted its core activity to compounds for the carpet industry. And with this a continued expansion was assured.
EOC decided to produc